The 2nd European Carotid Surgery Trial (ECST-2): rationale and protocol for a randomised clinical trial comparing immediate revascularisation versus optimised medical therapy alone in patients with symptomatic and asymptomatic carotid stenosis at low to intermediate risk of stroke

Background Carotid endarterectomy is currently recommended for patients with recently symptomatic carotid stenosis ≥50%, based on randomised trials conducted 30 years ago. Several factors such as carotid plaque ulceration, age and associated comorbidities might influence the risk-benefit ratio of ca...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Current controlled trials in cardiovascular medicine Ročník 23; číslo 1; s. 606 - 15
Hlavní autoři: Cheng, Suk Fun, van Velzen, Twan J., Gregson, John, Richards, Toby, Jäger, Hans Rolf, Simister, Robert, Kooi, M. Eline, de Borst, Gert J., Pizzini, Francesca B., Nederkoorn, Paul J., Brown, Martin M., Bonati, Leo H.
Médium: Journal Article
Jazyk:angličtina
Vydáno: London BioMed Central 27.07.2022
BioMed Central Ltd
Springer Nature B.V
BMC
Témata:
Asymptomatic
Atherosclerosis
Biomedicine
Brain research
Carotid arteries
Carotid endarterectomy
Carotid stenosis
Carotid stenting
Clinical trials
Diagnosis
Evaluation
Health Sciences
Hypotheses
Ischaemic stroke
Ischemia
Magnetic resonance imaging
Medicine
Medicine & Public Health
Patients
Risk factors
Risk prediction
Statistics for Life Sciences
Stenosis
Stroke
Stroke (Disease)
Study Protocol
Surgery
United States
United Kingdom > UK
Netherlands
Carotid stenosis
Plaque imaging
Carotid stenting
Carotid endarterectomy
Magnetic resonance imaging
Randomised controlled trial
Risk prediction
Ischaemic stroke
ISSN:1745-6215, 1745-6215
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Background Carotid endarterectomy is currently recommended for patients with recently symptomatic carotid stenosis ≥50%, based on randomised trials conducted 30 years ago. Several factors such as carotid plaque ulceration, age and associated comorbidities might influence the risk-benefit ratio of carotid revascularisation. A model developed in previous trials that calculates the future risk of stroke based on these features can be used to stratify patients into low, intermediate or high risk. Since the original trials, medical treatment has improved significantly. Our hypothesis is that patients with carotid stenosis ≥50% associated with a low to intermediate risk of stroke will not benefit from additional carotid revascularisation when treated with optimised medical therapy. We also hypothesise that prediction of future risk of stroke in individual patients with carotid stenosis can be improved using the results of magnetic resonance imaging (MRI) of the carotid plaque. Methods Patients are randomised between immediate revascularisation plus OMT versus OMT alone. Suitable patients are those with asymptomatic or symptomatic carotid stenosis ≥50% with an estimated 5-year risk of stroke of <20%, as calculated using the Carotid Artery Risk score. MRI of the brain at baseline and during follow-up will be used as a blinded measure to assess the incidence of silent infarction and haemorrhage, while carotid plaque MRI at baseline will be used to investigate the hypotheses that plaque characteristics determine future stroke risk and help identify a subgroup of patients that will benefit from revascularisation. An initial analysis will be conducted after recruitment of 320 patients with baseline MRI and a minimum of 2 years of follow-up, to provide data to inform the design and sample size for a continuation or re-launch of the study. The primary outcome measure of this initial analysis is the combined 2-year rate of any clinically manifest stroke, new cerebral infarct on MRI, myocardial infarction or periprocedural death. Discussion ECST-2 will provide new data on the efficacy of modern optimal medical therapy alone versus added carotid revascularisation in patients with carotid stenosis at low to intermediate risk of future stroke selected by individualised risk assessment. We anticipate that the results of baseline brain and carotid plaque MRI will provide data to improve the prediction of the risk of stroke and the effect of treatment in patients with carotid stenosis. Trial registration ISRCTN registry ISRCTN97744893 . Registered on 05 July 2012
AbstractList Abstract Background Carotid endarterectomy is currently recommended for patients with recently symptomatic carotid stenosis ≥50%, based on randomised trials conducted 30 years ago. Several factors such as carotid plaque ulceration, age and associated comorbidities might influence the risk-benefit ratio of carotid revascularisation. A model developed in previous trials that calculates the future risk of stroke based on these features can be used to stratify patients into low, intermediate or high risk. Since the original trials, medical treatment has improved significantly. Our hypothesis is that patients with carotid stenosis ≥50% associated with a low to intermediate risk of stroke will not benefit from additional carotid revascularisation when treated with optimised medical therapy. We also hypothesise that prediction of future risk of stroke in individual patients with carotid stenosis can be improved using the results of magnetic resonance imaging (MRI) of the carotid plaque. Methods Patients are randomised between immediate revascularisation plus OMT versus OMT alone. Suitable patients are those with asymptomatic or symptomatic carotid stenosis ≥50% with an estimated 5-year risk of stroke of <20%, as calculated using the Carotid Artery Risk score. MRI of the brain at baseline and during follow-up will be used as a blinded measure to assess the incidence of silent infarction and haemorrhage, while carotid plaque MRI at baseline will be used to investigate the hypotheses that plaque characteristics determine future stroke risk and help identify a subgroup of patients that will benefit from revascularisation. An initial analysis will be conducted after recruitment of 320 patients with baseline MRI and a minimum of 2 years of follow-up, to provide data to inform the design and sample size for a continuation or re-launch of the study. The primary outcome measure of this initial analysis is the combined 2-year rate of any clinically manifest stroke, new cerebral infarct on MRI, myocardial infarction or periprocedural death. Discussion ECST-2 will provide new data on the efficacy of modern optimal medical therapy alone versus added carotid revascularisation in patients with carotid stenosis at low to intermediate risk of future stroke selected by individualised risk assessment. We anticipate that the results of baseline brain and carotid plaque MRI will provide data to improve the prediction of the risk of stroke and the effect of treatment in patients with carotid stenosis. Trial registration ISRCTN registry ISRCTN97744893 . Registered on 05 July 2012
Background Carotid endarterectomy is currently recommended for patients with recently symptomatic carotid stenosis [greater than or equal to]50%, based on randomised trials conducted 30 years ago. Several factors such as carotid plaque ulceration, age and associated comorbidities might influence the risk-benefit ratio of carotid revascularisation. A model developed in previous trials that calculates the future risk of stroke based on these features can be used to stratify patients into low, intermediate or high risk. Since the original trials, medical treatment has improved significantly. Our hypothesis is that patients with carotid stenosis [greater than or equal to]50% associated with a low to intermediate risk of stroke will not benefit from additional carotid revascularisation when treated with optimised medical therapy. We also hypothesise that prediction of future risk of stroke in individual patients with carotid stenosis can be improved using the results of magnetic resonance imaging (MRI) of the carotid plaque. Methods Patients are randomised between immediate revascularisation plus OMT versus OMT alone. Suitable patients are those with asymptomatic or symptomatic carotid stenosis [greater than or equal to]50% with an estimated 5-year risk of stroke of <20%, as calculated using the Carotid Artery Risk score. MRI of the brain at baseline and during follow-up will be used as a blinded measure to assess the incidence of silent infarction and haemorrhage, while carotid plaque MRI at baseline will be used to investigate the hypotheses that plaque characteristics determine future stroke risk and help identify a subgroup of patients that will benefit from revascularisation. An initial analysis will be conducted after recruitment of 320 patients with baseline MRI and a minimum of 2 years of follow-up, to provide data to inform the design and sample size for a continuation or re-launch of the study. The primary outcome measure of this initial analysis is the combined 2-year rate of any clinically manifest stroke, new cerebral infarct on MRI, myocardial infarction or periprocedural death. Discussion ECST-2 will provide new data on the efficacy of modern optimal medical therapy alone versus added carotid revascularisation in patients with carotid stenosis at low to intermediate risk of future stroke selected by individualised risk assessment. We anticipate that the results of baseline brain and carotid plaque MRI will provide data to improve the prediction of the risk of stroke and the effect of treatment in patients with carotid stenosis. Trial registration ISRCTN registry ISRCTN97744893. Registered on 05 July 2012 Keywords: Carotid stenosis, Ischaemic stroke, Carotid endarterectomy, Carotid stenting, Risk prediction, Magnetic resonance imaging, Plaque imaging, Randomised controlled trial
BackgroundCarotid endarterectomy is currently recommended for patients with recently symptomatic carotid stenosis ≥50%, based on randomised trials conducted 30 years ago. Several factors such as carotid plaque ulceration, age and associated comorbidities might influence the risk-benefit ratio of carotid revascularisation. A model developed in previous trials that calculates the future risk of stroke based on these features can be used to stratify patients into low, intermediate or high risk. Since the original trials, medical treatment has improved significantly. Our hypothesis is that patients with carotid stenosis ≥50% associated with a low to intermediate risk of stroke will not benefit from additional carotid revascularisation when treated with optimised medical therapy. We also hypothesise that prediction of future risk of stroke in individual patients with carotid stenosis can be improved using the results of magnetic resonance imaging (MRI) of the carotid plaque.MethodsPatients are randomised between immediate revascularisation plus OMT versus OMT alone. Suitable patients are those with asymptomatic or symptomatic carotid stenosis ≥50% with an estimated 5-year risk of stroke of <20%, as calculated using the Carotid Artery Risk score. MRI of the brain at baseline and during follow-up will be used as a blinded measure to assess the incidence of silent infarction and haemorrhage, while carotid plaque MRI at baseline will be used to investigate the hypotheses that plaque characteristics determine future stroke risk and help identify a subgroup of patients that will benefit from revascularisation. An initial analysis will be conducted after recruitment of 320 patients with baseline MRI and a minimum of 2 years of follow-up, to provide data to inform the design and sample size for a continuation or re-launch of the study. The primary outcome measure of this initial analysis is the combined 2-year rate of any clinically manifest stroke, new cerebral infarct on MRI, myocardial infarction or periprocedural death.DiscussionECST-2 will provide new data on the efficacy of modern optimal medical therapy alone versus added carotid revascularisation in patients with carotid stenosis at low to intermediate risk of future stroke selected by individualised risk assessment. We anticipate that the results of baseline brain and carotid plaque MRI will provide data to improve the prediction of the risk of stroke and the effect of treatment in patients with carotid stenosis.Trial registrationISRCTN registry ISRCTN97744893. Registered on 05 July 2012
Background Carotid endarterectomy is currently recommended for patients with recently symptomatic carotid stenosis ≥50%, based on randomised trials conducted 30 years ago. Several factors such as carotid plaque ulceration, age and associated comorbidities might influence the risk-benefit ratio of carotid revascularisation. A model developed in previous trials that calculates the future risk of stroke based on these features can be used to stratify patients into low, intermediate or high risk. Since the original trials, medical treatment has improved significantly. Our hypothesis is that patients with carotid stenosis ≥50% associated with a low to intermediate risk of stroke will not benefit from additional carotid revascularisation when treated with optimised medical therapy. We also hypothesise that prediction of future risk of stroke in individual patients with carotid stenosis can be improved using the results of magnetic resonance imaging (MRI) of the carotid plaque. Methods Patients are randomised between immediate revascularisation plus OMT versus OMT alone. Suitable patients are those with asymptomatic or symptomatic carotid stenosis ≥50% with an estimated 5-year risk of stroke of <20%, as calculated using the Carotid Artery Risk score. MRI of the brain at baseline and during follow-up will be used as a blinded measure to assess the incidence of silent infarction and haemorrhage, while carotid plaque MRI at baseline will be used to investigate the hypotheses that plaque characteristics determine future stroke risk and help identify a subgroup of patients that will benefit from revascularisation. An initial analysis will be conducted after recruitment of 320 patients with baseline MRI and a minimum of 2 years of follow-up, to provide data to inform the design and sample size for a continuation or re-launch of the study. The primary outcome measure of this initial analysis is the combined 2-year rate of any clinically manifest stroke, new cerebral infarct on MRI, myocardial infarction or periprocedural death. Discussion ECST-2 will provide new data on the efficacy of modern optimal medical therapy alone versus added carotid revascularisation in patients with carotid stenosis at low to intermediate risk of future stroke selected by individualised risk assessment. We anticipate that the results of baseline brain and carotid plaque MRI will provide data to improve the prediction of the risk of stroke and the effect of treatment in patients with carotid stenosis. Trial registration ISRCTN registry ISRCTN97744893 . Registered on 05 July 2012
Carotid endarterectomy is currently recommended for patients with recently symptomatic carotid stenosis ≥50%, based on randomised trials conducted 30 years ago. Several factors such as carotid plaque ulceration, age and associated comorbidities might influence the risk-benefit ratio of carotid revascularisation. A model developed in previous trials that calculates the future risk of stroke based on these features can be used to stratify patients into low, intermediate or high risk. Since the original trials, medical treatment has improved significantly. Our hypothesis is that patients with carotid stenosis ≥50% associated with a low to intermediate risk of stroke will not benefit from additional carotid revascularisation when treated with optimised medical therapy. We also hypothesise that prediction of future risk of stroke in individual patients with carotid stenosis can be improved using the results of magnetic resonance imaging (MRI) of the carotid plaque.BACKGROUNDCarotid endarterectomy is currently recommended for patients with recently symptomatic carotid stenosis ≥50%, based on randomised trials conducted 30 years ago. Several factors such as carotid plaque ulceration, age and associated comorbidities might influence the risk-benefit ratio of carotid revascularisation. A model developed in previous trials that calculates the future risk of stroke based on these features can be used to stratify patients into low, intermediate or high risk. Since the original trials, medical treatment has improved significantly. Our hypothesis is that patients with carotid stenosis ≥50% associated with a low to intermediate risk of stroke will not benefit from additional carotid revascularisation when treated with optimised medical therapy. We also hypothesise that prediction of future risk of stroke in individual patients with carotid stenosis can be improved using the results of magnetic resonance imaging (MRI) of the carotid plaque.Patients are randomised between immediate revascularisation plus OMT versus OMT alone. Suitable patients are those with asymptomatic or symptomatic carotid stenosis ≥50% with an estimated 5-year risk of stroke of <20%, as calculated using the Carotid Artery Risk score. MRI of the brain at baseline and during follow-up will be used as a blinded measure to assess the incidence of silent infarction and haemorrhage, while carotid plaque MRI at baseline will be used to investigate the hypotheses that plaque characteristics determine future stroke risk and help identify a subgroup of patients that will benefit from revascularisation. An initial analysis will be conducted after recruitment of 320 patients with baseline MRI and a minimum of 2 years of follow-up, to provide data to inform the design and sample size for a continuation or re-launch of the study. The primary outcome measure of this initial analysis is the combined 2-year rate of any clinically manifest stroke, new cerebral infarct on MRI, myocardial infarction or periprocedural death.METHODSPatients are randomised between immediate revascularisation plus OMT versus OMT alone. Suitable patients are those with asymptomatic or symptomatic carotid stenosis ≥50% with an estimated 5-year risk of stroke of <20%, as calculated using the Carotid Artery Risk score. MRI of the brain at baseline and during follow-up will be used as a blinded measure to assess the incidence of silent infarction and haemorrhage, while carotid plaque MRI at baseline will be used to investigate the hypotheses that plaque characteristics determine future stroke risk and help identify a subgroup of patients that will benefit from revascularisation. An initial analysis will be conducted after recruitment of 320 patients with baseline MRI and a minimum of 2 years of follow-up, to provide data to inform the design and sample size for a continuation or re-launch of the study. The primary outcome measure of this initial analysis is the combined 2-year rate of any clinically manifest stroke, new cerebral infarct on MRI, myocardial infarction or periprocedural death.ECST-2 will provide new data on the efficacy of modern optimal medical therapy alone versus added carotid revascularisation in patients with carotid stenosis at low to intermediate risk of future stroke selected by individualised risk assessment. We anticipate that the results of baseline brain and carotid plaque MRI will provide data to improve the prediction of the risk of stroke and the effect of treatment in patients with carotid stenosis.DISCUSSIONECST-2 will provide new data on the efficacy of modern optimal medical therapy alone versus added carotid revascularisation in patients with carotid stenosis at low to intermediate risk of future stroke selected by individualised risk assessment. We anticipate that the results of baseline brain and carotid plaque MRI will provide data to improve the prediction of the risk of stroke and the effect of treatment in patients with carotid stenosis.ISRCTN registry ISRCTN97744893 . Registered on 05 July 2012.TRIAL REGISTRATIONISRCTN registry ISRCTN97744893 . Registered on 05 July 2012.
Carotid endarterectomy is currently recommended for patients with recently symptomatic carotid stenosis [greater than or equal to]50%, based on randomised trials conducted 30 years ago. Several factors such as carotid plaque ulceration, age and associated comorbidities might influence the risk-benefit ratio of carotid revascularisation. A model developed in previous trials that calculates the future risk of stroke based on these features can be used to stratify patients into low, intermediate or high risk. Since the original trials, medical treatment has improved significantly. Our hypothesis is that patients with carotid stenosis [greater than or equal to]50% associated with a low to intermediate risk of stroke will not benefit from additional carotid revascularisation when treated with optimised medical therapy. We also hypothesise that prediction of future risk of stroke in individual patients with carotid stenosis can be improved using the results of magnetic resonance imaging (MRI) of the carotid plaque. ECST-2 will provide new data on the efficacy of modern optimal medical therapy alone versus added carotid revascularisation in patients with carotid stenosis at low to intermediate risk of future stroke selected by individualised risk assessment. We anticipate that the results of baseline brain and carotid plaque MRI will provide data to improve the prediction of the risk of stroke and the effect of treatment in patients with carotid stenosis.
ArticleNumber 606
Audience Academic
Author de Borst, Gert J.
Richards, Toby
Kooi, M. Eline
Brown, Martin M.
Nederkoorn, Paul J.
Gregson, John
Bonati, Leo H.
van Velzen, Twan J.
Jäger, Hans Rolf
Simister, Robert
Cheng, Suk Fun
Pizzini, Francesca B.
Author_xml – sequence: 1
  givenname: Suk Fun
  surname: Cheng
  fullname: Cheng, Suk Fun
  organization: Stroke Research Centre, Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, University College London
– sequence: 2
  givenname: Twan J.
  surname: van Velzen
  fullname: van Velzen, Twan J.
  organization: Department of Neurology, Amsterdam UMC, University of Amsterdam
– sequence: 3
  givenname: John
  surname: Gregson
  fullname: Gregson, John
  organization: Department of Medical Statistics, London School of Hygiene and Tropical Medicine
– sequence: 4
  givenname: Toby
  surname: Richards
  fullname: Richards, Toby
  organization: Faculty of Health and Medical Sciences, Surgery, University of Western Australia
– sequence: 5
  givenname: Hans Rolf
  surname: Jäger
  fullname: Jäger, Hans Rolf
  organization: Neuroradiological Academic Unit, Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, University College London, Lysholm Department of Neuroradiology, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust
– sequence: 6
  givenname: Robert
  surname: Simister
  fullname: Simister, Robert
  organization: Stroke Research Centre, Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, University College London, Comprehensive Stroke Service, University College London Hospitals NHS Foundation Trust
– sequence: 7
  givenname: M. Eline
  surname: Kooi
  fullname: Kooi, M. Eline
  organization: Department of Radiology and Nuclear Medicine, CARIM School for Cardiovascular Diseases, Maastricht University
– sequence: 8
  givenname: Gert J.
  surname: de Borst
  fullname: de Borst, Gert J.
  organization: Department of Vascular Surgery, University Medical Center
– sequence: 9
  givenname: Francesca B.
  surname: Pizzini
  fullname: Pizzini, Francesca B.
  organization: Radiology, Department of Diagnostic and Public Health, University of Verona
– sequence: 10
  givenname: Paul J.
  surname: Nederkoorn
  fullname: Nederkoorn, Paul J.
  organization: Department of Neurology, Amsterdam UMC, University of Amsterdam
– sequence: 11
  givenname: Martin M.
  orcidid: 0000-0002-3273-1356
  surname: Brown
  fullname: Brown, Martin M.
  email: martin.brown@ucl.ac.uk
  organization: Stroke Research Centre, Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, University College London
– sequence: 12
  givenname: Leo H.
  surname: Bonati
  fullname: Bonati, Leo H.
  organization: Department of Neurology, University Hospital Basel, Department of Clinical Research, University of Basel, Research Department, Reha Rheinfelden
BookMark eNp9k01v1DAQhgMqoh_wA-BkiUs5pDh27DgckKpVgUqVOHQ5W45j77pN4mA7rba_ntlsVdoKVTk4Gr_vY49n5jDbG_xgsuxjgU-KQvAvsaCY0xwTkmNekjq_e50dFFXJck4Ktvfofz87jPEK45LWtHyb7VMm6qooyoNXH5Zrg8jQorMp-NGoAS1U8Mm16HIKKxM2aBmc6tDx2eJymZPPX1FQyflBdQYpsI0g9tp3yPqAFGwOre9dNC3SnRucBmuaAdr3owpuWCHX96Z1KhkUzI2KeuogHmcqujEhThH5MbkdZSudIWsT1LhBqoM3QG5AIxjMkCK6dWmN4qYfk-8hpudrqccBfZ9RTGbw0UWkEur8LUoeQMmEh-u4eI28BV3w1-Zd9saqLpr39-tR9vv72XLxM7_49eN8cXqRaybKlJe2JZWuYaGsYZWlvG6sKrTgShDGNLENLgnUwDaNsCURxlaCY1uRlrCmqulRdr7jtl5dyTG4XoWN9MrJOeDDSqoAaXRGKs5oayiuKt6UtKwbIZQoTS0oplbVJbC-7Vjj1EBWGh4oqO4J9OnO4NZy5W9kTYnghAHg-B4Q_J_JxCShDNp0nRqMn6IkvOYYc8YISD89k175KUBjgEpgwaqyoo9UK-gY6Qbr4Vy9hcpT6MCKs5psVSf_UcHXmt5pqLh1EH9iIDuDDj7GYOxDjgWW2-GQu-GQMBxyHg55BybxzKRdmvsOTnPdy1a6s8Zx28Mm_Ev2Bddf-iEq2g
CitedBy_id crossref_primary_10_23736_S0021_9509_23_12624_3
crossref_primary_10_23736_S0392_9590_25_05424_0
crossref_primary_10_1016_j_avsg_2024_09_042
crossref_primary_10_1007_s00772_024_01146_0
crossref_primary_10_1007_s11239_025_03112_3
crossref_primary_10_1016_j_jcin_2024_03_014
crossref_primary_10_1161_STROKEAHA_122_042172
crossref_primary_10_1016_j_hjc_2025_08_002
crossref_primary_10_1097_CRD_0000000000000497
crossref_primary_10_1177_17474930241264734
crossref_primary_10_1016_j_jvs_2023_11_004
crossref_primary_10_3390_diagnostics15131679
crossref_primary_10_1161_STROKEAHA_124_050020
crossref_primary_10_3390_life14010073
crossref_primary_10_1161_SVIN_125_001844
crossref_primary_10_1111_jep_13951
crossref_primary_10_1016_j_jvs_2023_03_502
crossref_primary_10_1161_STROKEAHA_124_048689
crossref_primary_10_1161_STROKEAHA_124_046129
crossref_primary_10_1016_j_avsg_2025_09_013
crossref_primary_10_1136_pn_2023_003918
crossref_primary_10_23736_S0392_9590_25_05308_8
crossref_primary_10_1016_j_jvs_2024_02_035
crossref_primary_10_1161_STROKEAHA_125_051981
crossref_primary_10_1055_a_2175_4029
crossref_primary_10_1016_S1474_4422_25_00107_3
crossref_primary_10_1080_01616412_2025_2523907
Cites_doi 10.1016/S0140-6736(04)16146-1
10.1016/j.ejvs.2009.01.011
10.1161/STROKEAHA.117.016051
10.1056/NEJMoa1802712
10.1016/S0140-6736(10)61009-4
10.1038/nrcardio.2011.151
10.1016/j.jcmg.2019.03.028
10.1161/STROKEAHA.110.579888
10.1016/S0140-6736(10)61197-X
10.3174/ajnr.A5488
10.1161/01.STR.0000054671.71777.C7
10.1016/j.jacc.2013.06.015
10.4414/cvm.2017.00499
10.1161/STROKEAHA.109.556068
10.1161/CIRCRESAHA.116.309115
10.1007/s00270-005-0384-6
10.1056/NEJMoa0912321
10.1093/brain/awq127
10.1056/NEJM199108153250701
10.1159/000313614
10.1161/01.STR.26.7.1231
10.1056/NEJM199811123392002
10.1016/S0140-6736(15)01309-4
10.1161/01.STR.22.6.711
10.1159/000477501
10.1161/01.CIR.97.18.1837
10.1056/NEJMoa070972
10.1001/archneur.63.12.1730
10.1016/S1474-4422(10)70057-0
10.1016/S0140-6736(05)70156-2
10.1016/S0140-6736(10)60239-5
10.1161/STROKEAHA.109.555052
10.1016/S0140-6736(98)11415-0
10.1053/j.semvascsurg.2017.04.005
10.1177/1747493019833017
10.1056/NEJMoa061894
10.1001/jama.1995.03520420037035
10.1212/01.WNL.0000169031.39264.ff
10.1161/STROKEAHA.108.516450
10.1161/01.STR.0000152333.75932.fe
10.1016/S0140-6736(02)09327-3
10.1161/CIRCINTERVENTIONS.119.007870
10.1016/S0140-6736(97)09292-1
10.1097/00005650-199711000-00002
10.1161/hc4201.097839
10.1016/S1474-4422(19)30035-3
10.1002/bjs.11136
10.1161/STROKEAHA.107.500603
10.1212/WNL.0b013e3181a711cb
ContentType Journal Article
Copyright The Author(s) 2022
COPYRIGHT 2022 BioMed Central Ltd.
The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022. The Author(s).
Copyright_xml – notice: The Author(s) 2022
– notice: COPYRIGHT 2022 BioMed Central Ltd.
– notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022. The Author(s).
DBID C6C
AAYXX
CITATION
3V.
7RV
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
FYUFA
GHDGH
K9.
KB0
M0S
M1P
NAPCQ
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s13063-022-06429-z
DatabaseName Springer Nature OA Free Journals
CrossRef
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
ProQuest One Community College
Coronavirus Research Database
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Medical Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

Publicly Available Content Database

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 7RV
  name: Nursing & Allied Health Database
  url: https://search.proquest.com/nahs
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1745-6215
EndPage 15
ExternalDocumentID oai_doaj_org_article_a653de30776b4349b88a84e98303fa94
PMC9328625
A711765922
10_1186_s13063_022_06429_z
GeographicLocations United States
United Kingdom--UK
Netherlands
GeographicLocations_xml – name: United States
– name: Netherlands
– name: United Kingdom--UK
GrantInformation_xml – fundername: National Institute for Health Research
  grantid: PB-PG-0609-19216
  funderid: http://dx.doi.org/10.13039/501100000272
– fundername: ;
  grantid: PB-PG-0609-19216
GroupedDBID ---
0R~
123
2-G
29Q
2WC
53G
5VS
6PF
7RV
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACUHS
ADBBV
ADRAZ
ADUKV
AEGXH
AENEX
AFKRA
AFPKN
AHBYD
AHYZX
AIAGR
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
C6C
CCPQU
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
NAPCQ
O5R
O5S
OVT
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
U2A
UKHRP
WOQ
WOW
~8M
AAYXX
AFFHD
CITATION
3V.
5GY
7XB
8FK
AHMBA
AZQEC
COVID
DWQXO
K9.
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
XSB
7X8
5PM
ID FETCH-LOGICAL-c584t-4fd27c94fd35b57f369bfa1c86a8255c2fb042215fbb8f428ef7860f72d25b793
IEDL.DBID DOA
ISICitedReferencesCount 30
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000831214700008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1745-6215
IngestDate Tue Oct 14 19:04:26 EDT 2025
Tue Nov 04 01:51:22 EST 2025
Sun Nov 09 12:58:42 EST 2025
Sun Oct 19 01:29:31 EDT 2025
Tue Nov 11 10:17:59 EST 2025
Tue Nov 04 17:52:32 EST 2025
Sat Nov 29 06:10:05 EST 2025
Tue Nov 18 21:40:40 EST 2025
Sat Sep 06 07:26:41 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Carotid stenosis
Plaque imaging
Carotid stenting
Carotid endarterectomy
Magnetic resonance imaging
Randomised controlled trial
Risk prediction
Ischaemic stroke
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c584t-4fd27c94fd35b57f369bfa1c86a8255c2fb042215fbb8f428ef7860f72d25b793
Notes ObjectType-Article-1
ObjectType-Evidence Based Healthcare-3
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ORCID 0000-0002-3273-1356
OpenAccessLink https://doaj.org/article/a653de30776b4349b88a84e98303fa94
PMID 35897114
PQID 2808574732
PQPubID 44365
PageCount 15
ParticipantIDs doaj_primary_oai_doaj_org_article_a653de30776b4349b88a84e98303fa94
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9328625
proquest_miscellaneous_2696006552
proquest_journals_2808574732
gale_infotracmisc_A711765922
gale_infotracacademiconefile_A711765922
crossref_primary_10_1186_s13063_022_06429_z
crossref_citationtrail_10_1186_s13063_022_06429_z
springer_journals_10_1186_s13063_022_06429_z
PublicationCentury 2000
PublicationDate 2022-07-27
PublicationDateYYYYMMDD 2022-07-27
PublicationDate_xml – month: 07
  year: 2022
  text: 2022-07-27
  day: 27
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle Current controlled trials in cardiovascular medicine
PublicationTitleAbbrev Trials
PublicationYear 2022
Publisher BioMed Central
BioMed Central Ltd
Springer Nature B.V
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: Springer Nature B.V
– name: BMC
References P Dolan (6429_CR40) 1997; 35
HJ Barnett (6429_CR3) 1998; 339
HJ Milionis (6429_CR25) 2009; 72
6429_CR1
MD Müller (6429_CR31) 2019; 12
TG Brott (6429_CR44) 2010; 363
M Sitzer (6429_CR35) 1995; 26
L Biasco (6429_CR22) 2017; 20
RM Kwee (6429_CR36) 2009; 40
North American Symptomatic Carotid Endarterectomy Trial Collaborators (6429_CR47) 1991; 325
T Saam (6429_CR48) 2013; 62
P Amarenco (6429_CR26) 2006; 355
J Ederle (6429_CR46) 2010; 375
AL Abbott (6429_CR28) 2009; 40
C Yuan (6429_CR37) 2001; 104
DJ McCabe (6429_CR39) 2005; 36
A Schindler (6429_CR18) 2020; 13
A Halliday (6429_CR6) 2004; 363
MW Vernooij (6429_CR12) 2007; 357
P Amarenco (6429_CR20) 2018; 378
A Halliday (6429_CR7) 2010; 376
PM Rothwell (6429_CR4) 2005; 365
GA Mensah (6429_CR21) 2017; 120
T Reiff (6429_CR51) 2020; 15
SB Coutts (6429_CR42) 2005; 65
JH Fu (6429_CR17) 2010; 30
Z Shah (6429_CR29) 2017; 44
H Sillesen (6429_CR24) 2008; 39
PM Rothwell (6429_CR5) 1999; 353
6429_CR32
S Schnaudigel (6429_CR14) 2008; 39
North American Symptomatic Carotid Endarterectomy Trial (6429_CR38) 1991; 22
N Cheung (6429_CR13) 2010; 133
M Canyigit (6429_CR15) 2007; 30
LH Bonati (6429_CR9) 2012; 9
SF Cheng (6429_CR33) 2017; 30
L Saba (6429_CR34) 2018; 39
ST Pendlebury (6429_CR41) 2010; 41
European Carotid Surgery Trialists’ Collaborative Group (6429_CR2) 1998; 351
L Saba (6429_CR49) 2019; 18
C Carotid Stenting Trialists (6429_CR10) 2010; 376
DW Kang (6429_CR43) 2006; 63
AR Naylor (6429_CR27) 2011; 9
MD Walker (6429_CR8) 1995; 273
Heart Protection Study Collaborative Group (6429_CR23) 2002; 360
PW Wilson (6429_CR45) 1998; 97
M Mott (6429_CR50) 2017; 48
G Howard (6429_CR11) 2016; 387
K Rerkasem (6429_CR30) 2009; 37
PM Rothwell (6429_CR19) 2003; 34
LH Bonati (6429_CR16) 2010; 9
References_xml – volume: 363
  start-page: 1491
  issue: 9420
  year: 2004
  ident: 6429_CR6
  publication-title: Lancet
  doi: 10.1016/S0140-6736(04)16146-1
– volume: 37
  start-page: 504
  issue: 5
  year: 2009
  ident: 6429_CR30
  publication-title: Eur J Vasc Endovasc Surg
  doi: 10.1016/j.ejvs.2009.01.011
– volume: 48
  start-page: e130
  issue: 5
  year: 2017
  ident: 6429_CR50
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.117.016051
– volume: 378
  start-page: 2182
  issue: 23
  year: 2018
  ident: 6429_CR20
  publication-title: New Engl J Med
  doi: 10.1056/NEJMoa1802712
– volume: 376
  start-page: 1062
  issue: 9746
  year: 2010
  ident: 6429_CR10
  publication-title: Lancet
  doi: 10.1016/S0140-6736(10)61009-4
– volume: 9
  start-page: 116
  issue: 2
  year: 2011
  ident: 6429_CR27
  publication-title: Nat Rev Cardiol
  doi: 10.1038/nrcardio.2011.151
– volume: 13
  start-page: 395
  issue: 2 Pt 1
  year: 2020
  ident: 6429_CR18
  publication-title: JACC Cardiovasc Imaging
  doi: 10.1016/j.jcmg.2019.03.028
– volume: 41
  start-page: 1290
  issue: 6
  year: 2010
  ident: 6429_CR41
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.110.579888
– volume: 376
  start-page: 1074
  issue: 9746
  year: 2010
  ident: 6429_CR7
  publication-title: Lancet
  doi: 10.1016/S0140-6736(10)61197-X
– volume: 39
  start-page: E9
  issue: 2
  year: 2018
  ident: 6429_CR34
  publication-title: AJNR Am J Neuroradiol
  doi: 10.3174/ajnr.A5488
– volume: 34
  start-page: 514
  year: 2003
  ident: 6429_CR19
  publication-title: Stroke
  doi: 10.1161/01.STR.0000054671.71777.C7
– volume: 62
  start-page: 1081
  issue: 12
  year: 2013
  ident: 6429_CR48
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2013.06.015
– volume: 20
  start-page: 169
  issue: 708
  year: 2017
  ident: 6429_CR22
  publication-title: Cardiovasc Med
  doi: 10.4414/cvm.2017.00499
– volume: 40
  start-page: e573
  issue: 10
  year: 2009
  ident: 6429_CR28
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.109.556068
– volume: 120
  start-page: 366
  issue: 2
  year: 2017
  ident: 6429_CR21
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.116.309115
– volume: 30
  start-page: 189
  issue: 2
  year: 2007
  ident: 6429_CR15
  publication-title: Cardiovasc Intervent Radiol
  doi: 10.1007/s00270-005-0384-6
– volume: 363
  start-page: 11
  issue: 1
  year: 2010
  ident: 6429_CR44
  publication-title: New Engl J Med
  doi: 10.1056/NEJMoa0912321
– volume: 9
  start-page: CD000515
  year: 2012
  ident: 6429_CR9
  publication-title: Cochrane Database Syst Rev
– volume: 133
  start-page: 1987
  year: 2010
  ident: 6429_CR13
  publication-title: Brain
  doi: 10.1093/brain/awq127
– volume: 325
  start-page: 445
  year: 1991
  ident: 6429_CR47
  publication-title: New Engl J Med
  doi: 10.1056/NEJM199108153250701
– volume: 30
  start-page: 51
  issue: 1
  year: 2010
  ident: 6429_CR17
  publication-title: Cerebrovasc Dis
  doi: 10.1159/000313614
– volume: 26
  start-page: 1231
  issue: 7
  year: 1995
  ident: 6429_CR35
  publication-title: Stroke
  doi: 10.1161/01.STR.26.7.1231
– volume: 339
  start-page: 1415
  issue: 20
  year: 1998
  ident: 6429_CR3
  publication-title: New Engl J Med
  doi: 10.1056/NEJM199811123392002
– volume: 387
  start-page: 1305
  issue: 10025
  year: 2016
  ident: 6429_CR11
  publication-title: Lancet
  doi: 10.1016/S0140-6736(15)01309-4
– volume: 22
  start-page: 711
  year: 1991
  ident: 6429_CR38
  publication-title: Stroke
  doi: 10.1161/01.STR.22.6.711
– volume: 44
  start-page: 150
  issue: 3-4
  year: 2017
  ident: 6429_CR29
  publication-title: Cerebrovasc Dis
  doi: 10.1159/000477501
– volume: 97
  start-page: 1837
  issue: 18
  year: 1998
  ident: 6429_CR45
  publication-title: Circulation
  doi: 10.1161/01.CIR.97.18.1837
– volume: 357
  start-page: 1821
  issue: 18
  year: 2007
  ident: 6429_CR12
  publication-title: New Engl J Med
  doi: 10.1056/NEJMoa070972
– ident: 6429_CR32
– volume: 63
  start-page: 1730
  issue: 12
  year: 2006
  ident: 6429_CR43
  publication-title: Arch Neurol
  doi: 10.1001/archneur.63.12.1730
– volume: 9
  start-page: 353
  issue: 4
  year: 2010
  ident: 6429_CR16
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(10)70057-0
– volume: 365
  start-page: 256
  issue: 9455
  year: 2005
  ident: 6429_CR4
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)70156-2
– volume: 375
  start-page: 985
  issue: 9719
  year: 2010
  ident: 6429_CR46
  publication-title: Lancet
  doi: 10.1016/S0140-6736(10)60239-5
– volume: 40
  start-page: 3017
  issue: 9
  year: 2009
  ident: 6429_CR36
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.109.555052
– volume: 353
  start-page: 2105
  issue: 9170
  year: 1999
  ident: 6429_CR5
  publication-title: Lancet
  doi: 10.1016/S0140-6736(98)11415-0
– volume: 30
  start-page: 8
  issue: 1
  year: 2017
  ident: 6429_CR33
  publication-title: Semin Vasc Surg
  doi: 10.1053/j.semvascsurg.2017.04.005
– volume: 15
  start-page: 638
  issue: 6
  year: 2020
  ident: 6429_CR51
  publication-title: Int J Stroke
  doi: 10.1177/1747493019833017
– volume: 355
  start-page: 549
  issue: 6
  year: 2006
  ident: 6429_CR26
  publication-title: New Engl J Med
  doi: 10.1056/NEJMoa061894
– volume: 273
  start-page: 1421
  issue: 18
  year: 1995
  ident: 6429_CR8
  publication-title: JAMA
  doi: 10.1001/jama.1995.03520420037035
– volume: 65
  start-page: 513
  issue: 4
  year: 2005
  ident: 6429_CR42
  publication-title: Neurology
  doi: 10.1212/01.WNL.0000169031.39264.ff
– volume: 39
  start-page: 3297
  issue: 12
  year: 2008
  ident: 6429_CR24
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.108.516450
– volume: 36
  start-page: 281
  year: 2005
  ident: 6429_CR39
  publication-title: Stroke
  doi: 10.1161/01.STR.0000152333.75932.fe
– volume: 360
  start-page: 7
  issue: 9326
  year: 2002
  ident: 6429_CR23
  publication-title: Lancet
  doi: 10.1016/S0140-6736(02)09327-3
– volume: 12
  start-page: e007870
  issue: 8
  year: 2019
  ident: 6429_CR31
  publication-title: Circ Cardiovasc Interv
  doi: 10.1161/CIRCINTERVENTIONS.119.007870
– volume: 351
  start-page: 1379
  issue: 9113
  year: 1998
  ident: 6429_CR2
  publication-title: Lancet
  doi: 10.1016/S0140-6736(97)09292-1
– volume: 35
  start-page: 1095
  issue: 11
  year: 1997
  ident: 6429_CR40
  publication-title: Med Care
  doi: 10.1097/00005650-199711000-00002
– volume: 104
  start-page: 2051
  issue: 17
  year: 2001
  ident: 6429_CR37
  publication-title: Circulation
  doi: 10.1161/hc4201.097839
– volume: 18
  start-page: 559
  issue: 6
  year: 2019
  ident: 6429_CR49
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(19)30035-3
– ident: 6429_CR1
  doi: 10.1002/bjs.11136
– volume: 39
  start-page: 1911
  issue: 6
  year: 2008
  ident: 6429_CR14
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.107.500603
– volume: 72
  start-page: 1816
  issue: 21
  year: 2009
  ident: 6429_CR25
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e3181a711cb
SSID ssj0043934
ssj0017864
Score 2.4474545
Snippet Background Carotid endarterectomy is currently recommended for patients with recently symptomatic carotid stenosis ≥50%, based on randomised trials conducted...
Background Carotid endarterectomy is currently recommended for patients with recently symptomatic carotid stenosis [greater than or equal to]50%, based on...
Carotid endarterectomy is currently recommended for patients with recently symptomatic carotid stenosis [greater than or equal to]50%, based on randomised...
BackgroundCarotid endarterectomy is currently recommended for patients with recently symptomatic carotid stenosis ≥50%, based on randomised trials conducted 30...
Carotid endarterectomy is currently recommended for patients with recently symptomatic carotid stenosis ≥50%, based on randomised trials conducted 30 years...
Abstract Background Carotid endarterectomy is currently recommended for patients with recently symptomatic carotid stenosis ≥50%, based on randomised trials...
SourceID doaj
pubmedcentral
proquest
gale
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 606
SubjectTerms Asymptomatic
Atherosclerosis
Biomedicine
Brain research
Carotid arteries
Carotid endarterectomy
Carotid stenosis
Carotid stenting
Clinical trials
Diagnosis
Evaluation
Health Sciences
Hypotheses
Ischaemic stroke
Ischemia
Magnetic resonance imaging
Medicine
Medicine & Public Health
Patients
Risk factors
Risk prediction
Statistics for Life Sciences
Stenosis
Stroke
Stroke (Disease)
Study Protocol
Surgery
SummonAdditionalLinks – databaseName: Nursing & Allied Health Database
  dbid: 7RV
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwEDcwEOKFb0RgoENCAgTRqPNhhxc0pk08wIRYQXuLbMeGaG1ckhS0_fWcHaejTOyFvlSKz40v_eV85zv_TMhTQyuFHxErU-Vxmoki5hVL4iTNE0mFYVJ4yvwPbH-fHx4Wn8KCWxfKKkeb6A11ZZVbI9-i3HGxpyyhbxc_YndqlMuuhiM0LpHLEzd3I57Z56-rLALjeTpulOH5Vof22mctaezc7iI-WZuMPGf_Wct8tlryr5Spn4n2bvyvDjfJ9eCDwvYAmlvkom5uk6sfQ5b9zoUIsQO0qWBcqgdXFtLXFRwMm6hh6mALz3d3DqYxffEG2rCkqEFgN8f9YBFggA4xCGxsKotw0hWM-zDBHxYCQwE8Kgn13G9h6TW0eiyODYVG4ApHlh1YNG7Dr8yH5BIMe8eOQcxso6FuIJDEduBWl6E7ni966ylp_bDEnxdU0AhB3tiu7kD0MLO_oLfgGDTa1XDq7gisQbnWHum75Mve7nTnfRyOkIgVelZ9nJqKMlXgV5LJjJkkL6QRE8VzgaFxpqiRjgRtkhkpucFQTBsEzWvDaEUzibbrHtloUIf7BCTGXlkiNPpsFGeXRCrDRS4q5TLikpmITEYslSrwq7tjPmalj7N4Xg74KxF_pcdfeRKRl6s-i4Fd5Fzpdw6iK0nHDO4v2PZbGQxNKfIsqXTiWJpkmqSF5FzwVBccfRUjijQizxzAS2e_cHhKhG0YqKRjAiu32WTCXK6dRmRzTRL_YrXePIK8DHavK08RHpEnq2bX09XyNdouUSbHqBmfYoYybO3VWtNsvaWpv3vucww3MAbPIvJqfAlPb_7vJ_fg_LE-JNeotwospmyTbPTtUj8iV9TPvu7ax96m_AYxj4bH
  priority: 102
  providerName: ProQuest
– databaseName: SpringerLINK Contemporary 1997-Present
  dbid: RSV
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9QwDA8wEOKFb0RhICMhAWIVXPqRlLcxbeIBJsQNtLcoSROodtdObQ-0_fU4aXpQBkhwLyc1zl3S2I4d278Q8tjSUuNHxtqWeZxmsoh5yZI4SfNEUWmZkh4y_y3b3-eHh8X7UBTWjdnuY0jSa2ov1jx_0aG29TFHGjujuYhPL5CLuN1xJ44f5p9G_Ys7bJKO5TG_7TfZgjxS_1l9fDZH8pdAqd9_9q7938ivk6vB3oTtgUFukPOmvkkuvwsR9VvnIuQToHUJ47E8uBSQviphPhRMw4FjUXi6uzM_iOmzV9CG40MDErs5nIcGmQnQ-AWJjXXZIOuYEsaaS_AXg8CQ7I7Dhmrpy1V6A60ZE2FDUhG4JJFVBw0qsuFXlkMgCYY6sROQi6Y2UNUQAGE7cCfJ0J0sj_vGw8_6YcmfH-gwI2TouumqDmQPi-Yb9A04tIx2PZyqO4LGIl3bHJnb5OPe7sHOmzhcFxFrtKL6OLUlZbrAryRTGbNJXigrZ5rnEt3gTFOrHODZLLNKcYtul7GM5y8toyXNFOqpO2SjxjncJaDQz8oSadA-o7iTJEpbLnNZahf9VsxGZDZykNABS91d6bEQ3qfiuRjWXOCaC7_m4jQiz9d9jgckkb9Sv3aMuaZ0KOD-QdN-FkGpCJlnSWkSh8ik0iQtFOeSp6bgaJdYWaQReeLYWjhdhcPTMpRc4CQd6pfYZrMZc3F1GpHNCSUusZ42j4Ihgo7rBOXudoSUJdj8aN3serq8vdo0K6TJ0UPGt5ghDZsI1GRm05a6-uJxztG1QH87i8jWKFY__vzPb-7ev5HfJ1eol0wWU7ZJNvp2ZR6QS_prX3XtQ69ZvgPN2X1_
  priority: 102
  providerName: Springer Nature
Title The 2nd European Carotid Surgery Trial (ECST-2): rationale and protocol for a randomised clinical trial comparing immediate revascularisation versus optimised medical therapy alone in patients with symptomatic and asymptomatic carotid stenosis at low to intermediate risk of stroke
URI https://link.springer.com/article/10.1186/s13063-022-06429-z
https://www.proquest.com/docview/2808574732
https://www.proquest.com/docview/2696006552
https://pubmed.ncbi.nlm.nih.gov/PMC9328625
https://doaj.org/article/a653de30776b4349b88a84e98303fa94
Volume 23
WOSCitedRecordID wos000831214700008&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVADU
  databaseName: BioMed Central_OA刊
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: RBZ
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: https://www.biomedcentral.com/search/
  providerName: BioMedCentral
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: DOA
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: M~E
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: 7X7
  dateStart: 20000401
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Nursing & Allied Health Database
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: 7RV
  dateStart: 20000401
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: BENPR
  dateStart: 20000401
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: PIMPY
  dateStart: 20000401
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: Springer Nature - Connect here FIRST to enable access
  customDbUrl:
  eissn: 1745-6215
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0043934
  issn: 1745-6215
  databaseCode: RSV
  dateStart: 20000401
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwEDcwEOIF8SkKozokJEAQjTofdnjbpk4gsapqy1SeItuxRbQ2mZIUtP31nJ2kLEzAC31Ilfjc2s7PZ5_v_DMhLw1NFX6Ep0waeUEoYo-nzPf8IPIlFYZJ4SjzP7PJhC-X8fTSUV82JqyhB24abk9EoZ9q37LOyMAPYsm54IGOOepeI2LHBIqzns6YanQwjrJ-0G2R4dFehZra-SupZyfcsXfRG4YcW_9VnXw1TvI3Z6kbg47ukbvt5BH2m0LfJ9d1_oDcPm7d4w-vDfClA81T6NbYwcZz1FkK82b3Myws3uD1-HC-8OibD1C2a4EaBGazpA0FIgNwJgsCE_O0QBzoFLoNlOBO-YAmch3LCNna7T2pNZS6i2ptI4TARnxsKihQKzW_sm68QtBs-joHsSpyDVkOLbtrBXZZGKrz9VldOC5ZVyxx-YFqa4TozIsqq0DUsCp-QF2Apb4ot8XJqlMoDMqVxal-RL4cjReHH7327AdP4ZSo9gKTUqZi_PJDGTLjR7E0YqR4JNCmDRU10rKXjUIjJTdoQ2nDePTeMJrSUKLSeUx2cqzDEwISjabQFxonWxSHBV8qw0UkUmVd2ZKZARl1UEhUS4xuz-dYJc5A4lHSwCdB-CQOPsnFgLzd5jlraEH-Kn1gEbaVtJTe7gECPWmBnvwL6APyyuIzsYoHi6dEu38CK2kpvJJ9Nhox6ySnA7Lbk8RXrPrJHcKTVmFVCeX2qIOA-Zj8Yptsc9ogvFwXG5SJ0NzFVgxRhvV6Rq9m_ZQ8--ZIy9FOQOM5HJB3XR_69ed_brmn_6PlnpE71HV95lG2S3bqcqOfk1vqe51V5ZDcYLMTe10yd-VDcvNgPJnOhk6l4N300_H0K97N5ic_AbUZfto
linkProvider Directory of Open Access Journals
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Zb9QwEDZVQcALNyJQYJBAgCAq6xx2kBAqpVWrHkLqVupbcBwborZJSVKq9kfxG5lxki1LRd_6wL6sFE92fc3lmfnM2HPLc40f5Wubx34YqcSXuQj8IIyDjCsrMuUg89fF5qbc2Um-zLBfQy0MpVUOMtEJ6rzSdEY-zyVhsYci4B8Pfvh0axRFV4crNLptsWaOj9Blaz6sfsb1fcH58tJ4ccXvbxXwNSrb1g9tzoVO8CuIskjYIE4yq0Zaxgq9pUhzmxEu1iiyWSYtWufGChm_s4LnPMoEgS-hyL-MclxQCpnYmTh4I6QLh8IcGc83qB9clJT7ZOYn_smU8nN3BJzVBGezM_8K0TrNt3zzf5uzW-xGb2PDQscUt9mMKe-wqxt9FsHdSx7yBvAyhyEUAZT20hY5bHVF4jAmtoRXS4tbY5-_fg91f2RqQOFrhG1RIQMBGvygsLHMK2QXk8NQZwruMhToEvxxUqHYdyU6rYHaDMm_fSIVUGLMYQMVCu_uV_a74Bl0tXHHoPaq0kBRQg-C2wCdnkNzvH_QVg5y13VL_flA9yNCJi6rpmhAtbBXHUFbASGE1JPuFM0uVBbp6mrX3GPbF7Iw99lsiWN4wCBD3zIKlEGblKP2DDJtpYpVrininwnrsdGwd1Pd48fTNSZ7qfMjZZx2-z3F_Z66_Z6eeOzN5J2DDj3lXOpPxBITSkI-dw-q-lvaC9JUxVGQm4BQqLIwCJNMSiVDk0i0xaxKQo-9JIZKST5j97Tqy0xwkIR0li6I0UhQLgH32NwUJS6xnm4emCrt5XqTnnKUx55NmulNylUsTXWINHESk2UfIY2YYuWpkU23lMV3h-2O7pSMeeSxtwPTn_75v2fu4fl9fcqurYw31tP11c21R-w6dxJJ-FzMsdm2PjSP2RX9sy2a-omTZ8C-XrQw-A3tiuOS
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bT9RAFB4JGuKLd2MV9Zho1GiDO73M1MQY5BIJSEiAZN_qdDqjDdBiWyTw0_x1njNtF1cibzy4L5t0Tnfndm4z53yHseeW5xo_ytc2j_0wUokvcxH4QRgHGVdWZMpB5m-IzU05HidbM-zXkAtDYZWDTHSCOq80nZEvcElY7KEI-ILtwyK2llc_Hv7wqYIU3bQO5TS6LbJuTo7RfWs-rC3jWr_gfHVlZ-mz31cY8DUq3tYPbc6FTvAriLJI2CBOMqtGWsYKPadIc5sRRtYoslkmLVrqxgoZv7OC5zzKBAExofi_KoJAUNkIMZ44eyOkC4ckHRkvNKgr3I0p98nkT_zTKUXo6gWc1wrnIzX_uq51WnD15v88f7fYjd72hsWOWW6zGVPeYXNf-uiCu1c85BngZQ7DFQVQOExb5LDdJY_DDrErvFpZ2t7x-ev3UPdHqQYUvkaYFxUyFqAjAAoby7xCNjI5DPmn4IqkQBf4jxMMxYFL3WkN1GYICu4DrIACZo4aqFCod79y0F2qQZczdwJqvyoNFCX04LgN0Kk6NCcHh23loHhdt9SfD3Q_ImTusmqKBlQL-9UxtBUQckg96U7R7EFlka6u9sw9tnspC3OfzZY4hgcMMvQ5o0AZtFU5atUg01aqWOWaIgEyYT02GvZxqntceSpvsp86_1LGabf3U9z7qdv76anH3kzeOexQVS6k_kTsMaEkRHT3oKq_pb2ATVUcBbkJCJ0qC4MwyaRUMjSJRBvNqiT02EtirpTkNnZPqz79BAdJCGjpohiNBMUYcI_NT1HiEuvp5oHB0l7eN-kZd3ns2aSZ3qQYxtJUR0gTJzFZ_BHSiCm2nhrZdEtZfHeY7-hmyZhHHns7CICzP__3zD28uK9P2RzKgHRjbXP9EbvOnXASPhfzbLatj8xjdk3_bIumfuJEG7Cvly0LfgPpyexG
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+2nd+European+Carotid+Surgery+Trial+%3A+rationale+and+protocol+for+a+randomised+clinical+trial+comparing+immediate+revascularisation+versus+optimised+medical+therapy+alone+in+patients+with+symptomatic+and+asymptomatic+carotid+stenosis+at+low+to+intermediate+risk+of+stroke&rft.jtitle=Trials&rft.au=Cheng%2C+Suk+Fun&rft.au=van+Velzen%2C+Twan+J&rft.au=Gregson%2C+John&rft.au=Richards%2C+Toby&rft.date=2022-07-27&rft.pub=BioMed+Central+Ltd&rft.issn=1745-6215&rft.eissn=1745-6215&rft.volume=23&rft.issue=1&rft_id=info:doi/10.1186%2Fs13063-022-06429-z&rft.externalDocID=A711765922
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1745-6215&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1745-6215&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1745-6215&client=summon